The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413426 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kunlin Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 561113, China. Hauptthemen laut MEDLINE: Astragalus propinquus, Proto-Oncogene Protein c-fli-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural National Science Foundation of China, he Science and Technology Department of Guizhou Province innovation and project grants, the Science and Technology Department of Guizhou Province grants.
Abstract (Originalsprache)
Astragalus membranaceus (AM) herb is a component of traditional Chinese medicine used to treat various cancers. Herein, we demonstrate a strong anti-leukemic effect of AM injected (Ai) into the mouse model of erythroleukemia induced by Friend virus. Chemical analysis combined with mass spectrometry of AM/Ai identified the compounds Betulinic acid, Kaempferol, Hederagenin, and formononetin, all major mediators of leukemia inhibition in culture and in vivo. Docking analysis demonstrated binding of these four compounds to FLI1, resulting in downregulation of its targets, induction of apoptosis, differentiation, and suppression of cell proliferation. Chemical composition analysis identified other compounds previously known having anti-tumor activity independent of the FLI1 blockade. Among these, Astragaloside-A (As-A) has marginal effect on cells in culture, but strongly inhibits leukemogenesis in vivo, likely through improvement of anti-tumor immunity. Indeed, both IDO1 and TDO2 were identified as targets of As-A, leading to suppression of tryptophane-mediated Kyn production and leukemia suppression. Moreover, As-A interacts with histamine decarboxylase (HDC), leading to suppression of anti-inflammatory genes TNF, IL1B/IL1A, TNFAIP3, and CXCR2, but not IL6. These results implicate HDC as a novel immune checkpoint mediator, induced in the tumor microenvironment to promote leukemia. Functional analysis of AM components may allow development of combination therapy with optimal anti-leukemia effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 561113, China.
- Natural Products Research Center of Guizhou Province, Guiyang 550014, China.
- Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network, Toronto, ON M5G 1L7, Canada.
- Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
ORCID-Profile: Xue-Zhong Yu, Yaacov Ben-David
Förderung
- the Natural National Science Foundation of China
- he Science and Technology Department of Guizhou Province innovation and project grants
- the Science and Technology Department of Guizhou Province grants
- the Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Aca-demic of Sciences Research Grant
- the Guizhou Medical University Research Grant
- Natural National Science Foundation of China
- Science and Technology Department of Guizhou Province innovation
- Science and Technology Department of Guizhou Province
Zitieren
APA
Yu, K., Tang, Y., Wang, C., Liu, W., Hu, M., Hu, A., Kuang, Y., Zacksenhaus, E., Yu, X. Z., Xiao, X., & Ben-David, Y. (2024). The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413426
Vancouver
Yu K, Tang Y, Wang C, Liu W, Hu M, Hu A, et al. The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413426
BibTeX
@article{Yu2024,
author = {Yu, Kunlin and Tang, Yao and Wang, Chunlin and Liu, Wuling and Hu, Maoting and Hu, Anling and Kuang, Yi and Zacksenhaus, Eldad and Yu, Xue-Zhong and Xiao, Xiao and Ben-David, Yaacov},
title = {The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413426}
}
EUVIMED